CRISPR Therapeutics CRSP Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:TaxesPayableCurrent.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's income taxes payable?
- CRISPR Therapeutics (CRSP) reported income taxes payable of $638K in Q1 2026.
- How has CRISPR Therapeutics's income taxes payable changed year-over-year?
- CRISPR Therapeutics's income taxes payable decreased by 48.6% year-over-year, from $1.24M to $638K.
- What is the long-term trend for CRISPR Therapeutics's income taxes payable?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's income taxes payable has grown at a -36.1% compound annual growth rate (CAGR), from $10.47M to $1.11M.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.